Zapis Capital Group

NeverEnding is a content creation platform based in Cleveland, Ohio, that was founded in 2020. The company focuses on empowering creators and teams to express their creativity through animations and social content. Its platform offers user-friendly tools for developing characters and avatars for various applications, including tabletop gaming, streaming, webcomics, and animated videos. By facilitating the creation of engaging characters and stories, NeverEnding enables users to connect with others who share similar interests, enhancing their gaming and storytelling experiences.

Axuall, Inc. is a workforce intelligence company that operates a digital network designed to verify identities, credentials, and authenticity across various sectors, including healthcare, insurance, and logistics. Founded in 2018 and based in Cleveland, Ohio, Axuall offers an integrated platform that facilitates smarter decision-making and expedites the onboarding process for healthcare providers. By leveraging real-time practitioner data, the company enhances workforce deployment and efficiency, and provides critical insights for network planning, analytics, and reporting. Its solutions aim to empower healthcare professionals by granting them control over their career identities while connecting health systems, staffing firms, and telehealth organizations to valuable data resources.

Groupmatics is an internet-based ticketing platform founded in 2012 and headquartered in Cleveland, Ohio. The company specializes in providing a white-label group event management tool, designed for use by professional sports teams and entertainment venues. Its platform streamlines the group sales process by facilitating the promotion, management, and purchase of tickets through customized event pages. This solution not only enhances the experience for sellers and buyers but also enables organizations to efficiently collect and manage attendee data. Originally named GroupAide, Groupmatics was established to offer a more secure and user-friendly alternative to traditional group ticket sales methods.

Scout RFP Inc. operates a cloud-based sourcing platform designed to streamline the enterprise buying process for both buyers and suppliers. The platform automates the management of requests for proposals and buying events across various sectors, including engineering, finance, and software development. Founded in 2013 and based in San Francisco, California, Scout RFP provides procurement teams with tools to enhance collaboration, visibility, and effectiveness in managing their projects. As a subsidiary of Workday, Scout RFP is recognized for driving profitability and reducing risks in enterprise commerce, ultimately helping organizations achieve better business outcomes. The company is supported by several investors, including Scale Ventures, Menlo Ventures, Workday Ventures, Salesforce Ventures, New View Capital, and GV.

Groupmatics is an internet-based ticketing platform founded in 2012 and headquartered in Cleveland, Ohio. The company specializes in providing a white-label group event management tool, designed for use by professional sports teams and entertainment venues. Its platform streamlines the group sales process by facilitating the promotion, management, and purchase of tickets through customized event pages. This solution not only enhances the experience for sellers and buyers but also enables organizations to efficiently collect and manage attendee data. Originally named GroupAide, Groupmatics was established to offer a more secure and user-friendly alternative to traditional group ticket sales methods.

GenomOncology, LLC is a Cleveland-based genomics technology and services company dedicated to enhancing precision medicine by converting next-generation sequencing (NGS) data into actionable insights for clinicians and researchers. The company offers the GO Clinical Workbench, a decision support tool that translates raw sequencing data into detailed clinical reports based on the molecular profile of each patient's tumor genome. Additionally, GenomOncology provides GenomAnalytics, a research platform facilitating rapid, near real-time genome analysis and exploration for new discoveries. IgniteIQ is another solution offered, which extracts clinically relevant data from various reports and converts it into discrete data elements. The company also supports assay validation, integration with laboratory information systems, and custom feature development. Established in 2012, GenomOncology aims to improve patient outcomes through advanced data interpretation in oncology.

COMS Interactive is a leader in the post-acute care industry, specializing in the management of clinical risk through its software-as-a-service (SaaS) product suite, Daylight IQ®. This platform serves as a point-of-care clinical decision support tool that standardizes care and documentation, allowing healthcare professionals to proactively manage chronic diseases and monitor changes in patient conditions. Daylight IQ® provides real-time, patient-centric assessments and facilitates automated outcome reporting, which enhances patient visibility and enables step-by-step interventions tailored to individual cases. By utilizing this innovative technology, healthcare providers can improve clinical outcomes and effectively manage risk and time associated with patient care.

Cleveland HeartLab, Inc. is a specialty clinical laboratory dedicated to the prevention and management of cardiovascular disease (CVD). The company specializes in novel biomarker technologies and develops proprietary diagnostic tests aimed at improving the early identification of individuals at risk for CVD. Cleveland HeartLab offers a range of clinical laboratory services, including an inflammatory panel for CVD, advanced CVD risk profiles, and lipid panels. By focusing on innovative molecular biomarker technologies, the company seeks to enhance the management and reduction of inflammation, ultimately contributing to better cardiovascular health outcomes.

Cleveland HeartLab, Inc. is a specialty clinical laboratory dedicated to the prevention and management of cardiovascular disease (CVD). The company specializes in novel biomarker technologies and develops proprietary diagnostic tests aimed at improving the early identification of individuals at risk for CVD. Cleveland HeartLab offers a range of clinical laboratory services, including an inflammatory panel for CVD, advanced CVD risk profiles, and lipid panels. By focusing on innovative molecular biomarker technologies, the company seeks to enhance the management and reduction of inflammation, ultimately contributing to better cardiovascular health outcomes.

Onosys, operating as O-Web Technologies LTD, is a digital ordering platform based in Cleveland, Ohio, that serves restaurant chains by enhancing their brand experience for modern consumers. Established in 2003, Onosys offers an enterprise-level platform that integrates various functions, including ordering, loyalty programs, payments, call centers, and marketing tools, into a single customizable solution. This comprehensive platform is designed to optimize online ordering channels and improve customer engagement and sales. Restaurant brands benefit from Onosys' flexibility and capability to tailor the ordering experience to their specific needs, while also receiving industry-leading support and service. Through its innovative technology, Onosys helps restaurants provide convenience and personalization to their customers.